EFFECT OF COUNTRY-OF-ORIGIN ON THE PROPERTIES OF MICROCRYSTALLINE CELLULOSE

被引:52
作者
LANDIN, M
MARTINEZPACHECO, R
GOMEZAMOZA, JL
SOUTO, C
CONCHEIRO, A
ROWE, RC
机构
[1] UNIV SANTIAGO,FAC FARM,DEPT FARMACOL FARM & TECNOL FARMACEUT,E-15706 SANTIAGO,SPAIN
[2] ICI PLC,DIV PHARMACEUT,MACCLESFIELD SK10 4TG,CHESHIRE,ENGLAND
关键词
MICROCRYSTALLINE CELLULOSE; LIGNIN; HEMICELLULOSE; CRYSTALLINITY; ENTHALPY OF IMMERSION; EQUILIBRIUM HUMIDITY; RHEOLOGICAL PROPERTIES;
D O I
10.1016/0378-5173(93)90331-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The characteristics of four brands of microcrystalline cellulose manufactured in Finland, India, Ireland and Japan have been determined; all four were nominally similar to Avicel PH 101. There were significant differences in lignin content, hemicellulose sugars content and composition, presence or absence of cellulose II, enthalpy of immersion, particle size and flow properties. Crystallinity correlated with water-cellulose interaction, and particle size with flow properties.
引用
收藏
页码:123 / 131
页数:9
相关论文
共 23 条
[1]  
ALBERSHEIM PETER, 1967, CARBOHYD RES, V5, P340, DOI 10.1016/S0008-6215(00)80510-8
[2]  
ALLEN T, 1978, PARTICLE SIZE MEASUR
[3]  
[Anonymous], 1965, CHEM ENG-NEW YORK
[4]  
Atalla R. H., 1976, APPL POLYM S, V28, P659
[5]  
BAEHR M, 1991, EUR J PHARM BIOPHARM, V37, P136
[6]  
Chatrath M, 1991, J PHARM PHARM S, V43, p7P
[7]   THIGMOMORPHOGENESIS IN BRYONIA-DIOICA - CHANGES IN SOLUBLE AND WALL PEROXIDASES, PHENYLALANINE AMMONIA-LYASE ACTIVITY, CELLULOSE, LIGNIN CONTENT AND MONOMERIC CONSTITUENTS [J].
DEJAEGHER, G ;
BOYER, N ;
GASPAR, T .
PLANT GROWTH REGULATION, 1985, 3 (02) :133-148
[8]   COMPARATIVE TABLETING PROPERTIES OF 16 MICROCRYSTALLINE CELLULOSES [J].
DOELKER, E ;
MORDIER, D ;
ITEN, H ;
HUMBERTDROZ, P .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1987, 13 (9-11) :1847-1875
[9]   DEGREES OF CRYSTALLINITY AND POLYMERIZATION OF MODIFIED CELLULOSE POWDERS FOR DIRECT TABLETING [J].
DOELKER, E ;
GURNY, R ;
SCHURZ, J ;
JANOSI, A ;
MATIN, N .
POWDER TECHNOLOGY, 1987, 52 (03) :207-213
[10]  
HUMBERTDROZ P, 1982, PHARM ACTA HELV, V57, P136